Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0686 | 0.3604 | 0.3604 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0686 | 0.3604 | 0.3557 |
Echinococcus multilocularis | decaprenyl diphosphate synthase subunit 1 | 0.0517 | 0.2702 | 0.2702 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.1885 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.0517 | 0.2702 | 0.5 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0024 | 0.0074 | 0.0074 |
Leishmania major | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0517 | 0.2702 | 0.5 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.1885 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0517 | 0.2702 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0024 | 0.0074 | 0.0074 |
Brugia malayi | Pre-SET motif family protein | 0.0166 | 0.0833 | 0.0765 |
Schistosoma mansoni | P2X receptor subunit | 0.0196 | 0.0994 | 0.0927 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0686 | 0.3604 | 0.1235 |
Echinococcus granulosus | prenyl decaprenyl diphosphate synthase | 0.0517 | 0.2702 | 0.2702 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.1885 | 1 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0051 | 0.0218 | 0.0218 |
Leishmania major | polyprenyl synthase, putative | 0.0686 | 0.3604 | 0.1235 |
Echinococcus multilocularis | prenyl (decaprenyl) diphosphate synthase | 0.0517 | 0.2702 | 0.2702 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0517 | 0.2702 | 0.2702 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.1885 | 1 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0686 | 0.3604 | 0.3604 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.1885 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0196 | 0.0994 | 0.0994 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0024 | 0.0074 | 0.0074 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.0517 | 0.2702 | 0.5 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0117 | 0.0571 | 0.0501 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0686 | 0.3604 | 0.5 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.1885 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.0517 | 0.2702 | 0.5 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0166 | 0.0833 | 0.0833 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.1885 | 1 | 1 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0517 | 0.2702 | 0.5 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0517 | 0.2702 | 0.2648 |
Echinococcus granulosus | decaprenyl diphosphate synthase subunit 1 | 0.0517 | 0.2702 | 0.2702 |
Schistosoma mansoni | glutathione synthetase | 0.0517 | 0.2702 | 0.2648 |
Brugia malayi | geranylgeranyl pyrophosphate synthetase | 0.0686 | 0.3604 | 0.3557 |
Schistosoma mansoni | trans-prenyltransferase | 0.0517 | 0.2702 | 0.2648 |
Onchocerca volvulus | 0.0189 | 0.0956 | 1 | |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0686 | 0.3604 | 0.1235 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.1885 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0196 | 0.0994 | 0.0927 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.1885 | 1 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0023 | 0.0069 | 0.0069 |
Plasmodium vivax | octaprenyl pyrophosphate synthase, putative | 0.0517 | 0.2702 | 0.2648 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0051 | 0.0218 | 0.0218 |
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0686 | 0.3604 | 0.3604 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0517 | 0.2702 | 0.2648 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0517 | 0.2702 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0074 | 0.0074 |
Schistosoma mansoni | P2X receptor subunit | 0.0117 | 0.0571 | 0.0501 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.1885 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Survival (functional) | = 33 % | Average percent survival of C57Bl/6 mice thymocytes from dexamethasone (5 uM) induced apoptosis at 5 uM | ChEMBL. | 16190767 |
Survival (functional) | = 33 % | Average percent survival of C57Bl/6 mice thymocytes from dexamethasone (5 uM) induced apoptosis at 5 uM | ChEMBL. | 16190767 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.